Open AccessManaging advanced EGFR-positive NSCLC - a short review
Author(s) -
Alexandru Grigorescu
Publication year - 2017
Publication title -
oncolog-hematolog.ro
Language(s) - Uncategorized
Resource type - Journals
eISSN - 2066-8716
pISSN - 2066-8260
DOI - 10.26416/onhe.39.2.2017.727
Subject(s) - afatinib , erlotinib , gefitinib , medicine , oncology , osimertinib , lung cancer , acquired resistance , disease , chemotherapy , intensive care medicine , cancer , epidermal growth factor receptor